|
US2020029911A1
|
|
System and method of patient monitoring and signal quality analysis
|
|
US2019209061A1
|
|
System and method for non-invasive monitoring of hematocrit concentration
|
|
US2019209055A1
|
|
System and method for non-invasive monitoring of advanced glycation end-products (age)
|
|
US2019209060A1
|
|
System and method for non-invasive monitoring of hemoglobin
|
|
US2017100053A1
|
|
Medical device and methods of monitoring a patient with renal dysfunction
|
|
US2018132793A1
|
|
System and methods of processing accelerometer signals
|
|
US2018116538A1
|
|
Method and apparatus for detecting electrocardiographic abnormalities based on monitored high frequency QRS potentials
|
|
US2018116598A1
|
|
System and methods of determining etiology of undiagnosed symptomatic events
|
|
US2018116536A1
|
|
System and method for onset/offset capture
|
|
US2018085022A1
|
|
System and method for cardiac monitoring using adaptive sensitivity/specificity levels
|
|
US2018085021A1
|
|
System and method for cardiac monitoring using rate-based sensitivity levels
|
|
US2017172413A1
|
|
System and method to flag arrhythmia episodes for urgent review
|
|
US2017119274A1
|
|
System and method to determine premature ventricular contraction (PVC) type and burden
|
|
US2016361024A1
|
|
System and method for monitoring and classifying atrial fibrillations
|
|
EP3110311A1
|
|
Separable monitoring device and method
|
|
US2016135708A1
|
|
QT interval determination methods and related devices
|
|
CN105873504A
|
|
Congestive heart failure risk status determination methods and related devices
|
|
EP2375968A2
|
|
Patient monitoring systems and methods
|
|
EP2257216A1
|
|
Heart failure decompensation prediction based on cardiac rhythm
|
